These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12443784)

  • 21. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of bacterial peptide deformylase by biaryl acid analogs.
    Green BG; Toney JH; Kozarich JW; Grant SK
    Arch Biochem Biophys; 2000 Mar; 375(2):355-8. PubMed ID: 10700392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding affinities and geometries of various metal ligands in peptide deformylase inhibitors.
    Madison V; Duca J; Bennett F; Bohanon S; Cooper A; Chu M; Desai J; Girijavallabhan V; Hare R; Hruza A; Hendrata S; Huang Y; Kravec C; Malcolm B; McCormick J; Miesel L; Ramanathan L; Reichert P; Saksena A; Wang J; Weber PC; Zhu H; Fischmann T
    Biophys Chem; 2002 Dec; 101-102():239-47. PubMed ID: 12488004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.
    Margolis P; Hackbarth C; Lopez S; Maniar M; Wang W; Yuan Z; White R; Trias J
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2432-5. PubMed ID: 11502510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors.
    Shen G; Zhu J; Simpson AM; Pei D
    Bioorg Med Chem Lett; 2008 May; 18(10):3060-3. PubMed ID: 18093832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach.
    Chen D; Hackbarth C; Ni ZJ; Wu C; Wang W; Jain R; He Y; Bracken K; Weidmann B; Patel DV; Trias J; White RJ; Yuan Z
    Antimicrob Agents Chemother; 2004 Jan; 48(1):250-61. PubMed ID: 14693547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
    Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.
    Fu H; Dahlgren C; Bylund J
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2545-50. PubMed ID: 12878517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
    Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peptide-deformylase inhibitors, a new class of antibiotics].
    Dubreuil L
    Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives.
    Takayama W; Shirasaki Y; Sakai Y; Nakajima E; Fujita S; Sakamoto-Mizutani K; Inoue J
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3273-6. PubMed ID: 12951107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
    Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a potent peptide deformylase inhibitor from a rationally designed combinatorial library.
    Wei Y; Yi T; Huntington KM; Chaudhury C; Pei D
    J Comb Chem; 2000; 2(6):650-7. PubMed ID: 11126293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of Escherichia coli LpxC: in vitro enzyme inhibition and antibacterial properties.
    Pirrung MC; Tumey LN; McClerren AL; Raetz CR
    J Am Chem Soc; 2003 Feb; 125(6):1575-86. PubMed ID: 12568618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
    Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
    Boularot A; Giglione C; Petit S; Duroc Y; Alves de Sousa R; Larue V; Cresteil T; Dardel F; Artaud I; Meinnel T
    J Med Chem; 2007 Jan; 50(1):10-20. PubMed ID: 17201406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of peptide deformylase inhibitors against gram-positive pathogens.
    Wise R; Andrews JM; Ashby J
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1117-8. PubMed ID: 11897602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents.
    McAllister LA; Montgomery JI; Abramite JA; Reilly U; Brown MF; Chen JM; Barham RA; Che Y; Chung SW; Menard CA; Mitton-Fry M; Mullins LM; Noe MC; O'Donnell JP; Oliver RM; Penzien JB; Plummer M; Price LM; Shanmugasundaram V; Tomaras AP; Uccello DP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6832-8. PubMed ID: 23046961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of peptide deformylase inhibitors.
    Chen D; Yuan Z
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1107-16. PubMed ID: 16144495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.